Evidence supports the use of non-invasive vagus nerve stimulation (nVNS; gammaCore®) as a promising therapeutic option for patients with cluster headache (CH). We conducted this audit of real-world data from patients with CH, the majority of whom were treatment refractory, to explore early UK clinical experience with nVNS used acutely, preventively, or both. We retrospectively...
Background In the PREVention and Acute treatment of chronic cluster headache (PREVA) study, attack frequency reductions from baseline were significantly more pronounced with non-invasive vagus nerve stimulation plus standard of care (nVNS + SoC) than with SoC alone. Given the intensely painful and frequent nature of chronic cluster headache attacks, additional patient-centric...
In the PREVention and Acute treatment of chronic cluster headache (PREVA) study, attack frequency reductions from baseline were significantly more pronounced with non-invasive vagus nerve stimulation plus standard of care (nVNS + SoC) than with SoC alone. Given the intensely painful and frequent nature of chronic cluster headache attacks, additional patient-centric outcomes...
Following publication of the original article [1], the authors notified us that a part of the Figure 3 legend was omitted during proofing stage.
Following publication of the original article [1], the authors notified us o that the Table 1 citation within the legend was not presented as initially requested.
); Gabriella Egeo, MD, PhD (Subinvestigator); Luisa Fofi, MD (Subinvestigator). electroCore Study Team: Eric Liebler (Senior Vice President, Neurology); Annelie Andersson (Senior Director, Clinical Director
, PhD (Subinvestigator); Luisa Fofi, MD (Subinvestigator). electroCore Study Team: Eric Liebler (Senior Vice President, Neurology); Annelie Andersson (Senior Director, Clinical Director); Lia Spitzer ... Grazzi, MD, Cristina Tassorelli, MD, PhD, and Eric Liebler contributed to the PRESTO study design and provided detailed input into the development of the manuscript. All primary investigators were involved
Background Menstrual migraine and menstrually related migraine attacks are typically longer, more disabling, and less responsive to medications than non-menstrual attacks. The aim of this study was to evaluate the efficacy, safety, and tolerability of non-invasive vagus nerve stimulation for the prophylactic treatment of menstrual migraine/menstrually related migraine. Methods...
Menstrual migraine and menstrually related migraine attacks are typically longer, more disabling, and less responsive to medications than non-menstrual attacks. The aim of this study was to evaluate the efficacy, safety, and tolerability of non-invasive vagus nerve stimulation for the prophylactic treatment of menstrual migraine/menstrually related migraine. Fifty-six enrolled...
electroCore. Eric Liebler is an employee of electroCore. Dr. Gabriella Egeo, Dr. Gennaro Bussone, and Ms. Anna Maria Padovan have no competing interests to declare. Authors’ contributions PB and LG developed
electroCore. Dr. Licia Grazzi has also served as a consultant and scientific advisor for Allergan and electroCore. Eric Liebler is an employee of electroCore. Dr. Gabriella Egeo, Dr. Gennaro Bussone, and Ms
(Principal Investigator); Cinzia Aurilia, MD (Subinvestigator); Gabriella Egeo, MD, PhD (Subinvestigator); Luisa Fofi, MD (Subinvestigator). electroCore Study Team: Eric Liebler (Senior Vice President ... participant data will not be shared. Authors’ contributions Licia Grazzi, MD, Cristina Tassorelli, MD, PhD, and Eric Liebler contributed to the PRESTO study design and provided detailed input into the
. Simon Walker is an employee of Cogentia Healthcare Consulting Ltd. Eric Liebler is an employee of electroCore, LLC, and receives stock ownership. Charly Gaul has received honoraria from Allergan, Inc
investigator fees paid to the Walton Centre. Simon Walker is an employee of Cogentia Healthcare Consulting Ltd. Eric Liebler is an employee of electroCore, LLC, and receives stock ownership. Charly Gaul has
